Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 85/100

Failure Rate

20.0%

1 terminated/withdrawn out of 5 trials

Success Rate

0.0%

-86.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

1 of 0 completed trials have results

Key Signals

4 recruiting1 with results

Enrollment Performance

Analytics

N/A
4(100.0%)
4Total
N/A(4)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (5)

Showing 5 of 5 trials
NCT06610539Recruiting

PAS 1ml Magtrace® for Sentinel Lymph Node Biopsy in Breast Cancer Patients

Role: lead

NCT05142787Not ApplicableRecruiting

Magseed Pro(R)/ Sentimag(R) Gen3

Role: lead

NCT03796559Not ApplicableRecruiting

Magseed Enabled Long-Term Localization of Axillary Lymph Nodes

Role: lead

NCT02445456Not ApplicableTerminated

Feasibility of Sentinel Lymph Node Biopsy in Rectal Cancer

Role: collaborator

NCT05427071Not ApplicableRecruiting

Magnetic Marker Localization for Occult Breast Cancer and Target Axillary Dissection in Node-positive Breast Cancer Post-neoadjuvant Chemotherapy

Role: collaborator

All 5 trials loaded